top of page
CONNECT M3
BANK
Article
TRIAL LEADER IS DEFICIENT
Martin Landray speaks of HCQ doses used in Oxford Recovery Trial
AB-3144F
FRANCE SOIR
Facebook
X (Twitter)
WhatsApp
LinkedIn
Pinterest
Copy link
Also see
these related articles
COVID
Hydroxychloroquine
bottom of page